{"id":"W4388495146","doi":"10.1136/ijgc-2023-igcs.473","title":"TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study","year":2023,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Carboplatin; Medicine; Chemotherapy; Paclitaxel; Internal medicine; Placebo; Cohort; Ovarian cancer; Gastroenterology; Oncology; Cancer; Urology; Cisplatin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001273474,0.00156507,0.003268257,0.0005676018,0.000508493,0.0008456378,0.00103528,0.00236471,0.01417606],"category_scores_gemma":[0.0008730465,0.0006906257,0.001797384,0.0005107528,0.001290585,0.0007688001,0.00030676,0.002916859,0.002074281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005430516,"about_ca_system_score_gemma":0.001412036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275418,"about_ca_topic_score_gemma":0.00275836,"domain_scores_codex":[0.999545,0.0002224117,0.00003193988,0.00008566226,0.00002979453,0.00008514134],"domain_scores_gemma":[0.9993759,0.0001531624,0.0001155333,0.00005927919,0.00004434508,0.0002517832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.978641,0.00683612,0.0002638659,0.0003763929,0.0004867345,0.00002444295,0.00001562248,0.0001177664,0.004033199,0.00007432748,0.0007007463,0.008429872],"study_design_scores_gemma":[0.9244576,0.07320537,0.0009912066,0.00001736298,0.0003313429,0.00001381344,0.000009995,0.0001106614,0.000376777,0.0000478707,0.0004305958,0.000007414666],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759822,0.004910467,0.001085991,0.001034525,0.001107604,0.006324364,0.003821793,0.0003072029,0.005425842],"genre_scores_gemma":[0.9679459,0.003449579,0.001963239,0.002452705,0.00100919,0.006205404,0.003458585,0.00006633707,0.01344902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01417606,"threshold_uncertainty_score":0.04742366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03222303950896773,"score_gpt":0.368400302273416,"score_spread":0.3361772627644483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}